Legacy Capital Group California Inc. lessened its position in shares of The Allstate Co. (NYSE:ALL – Free Report) by 6.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,114 shares of the insurance provider’s stock after selling 267 shares during the period. Legacy Capital Group California Inc.’s holdings in Allstate were worth $780,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds have also bought and sold shares of the company. Northwest Investment Counselors LLC purchased a new position in shares of Allstate during the 3rd quarter valued at $28,000. Versant Capital Management Inc boosted its position in shares of Allstate by 70.9% during the 2nd quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 78 shares during the last quarter. Family Firm Inc. purchased a new stake in Allstate in the second quarter valued at approximately $38,000. MCF Advisors LLC raised its position in shares of Allstate by 33.9% during the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock valued at $53,000 after buying an additional 84 shares in the last quarter. Finally, First Command Advisory Services Inc. purchased a new stake in Allstate during the second quarter valued at about $58,000. 76.47% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of research analysts have commented on ALL shares. Piper Sandler increased their price target on shares of Allstate from $188.00 to $196.00 and gave the company an “overweight” rating in a research report on Friday, August 16th. BMO Capital Markets lifted their target price on shares of Allstate from $205.00 to $214.00 and gave the stock an “outperform” rating in a research report on Friday, October 18th. Barclays began coverage on shares of Allstate in a research report on Wednesday, September 4th. They set an “underweight” rating and a $175.00 price target for the company. Bank of America lifted their price objective on Allstate from $216.00 to $233.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Finally, Keefe, Bruyette & Woods raised their price target on Allstate from $199.00 to $208.00 and gave the stock an “outperform” rating in a research report on Monday, August 12th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $206.44.
Insiders Place Their Bets
In other news, insider John E. Dugenske sold 36,367 shares of the company’s stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the transaction, the insider now directly owns 27,364 shares of the company’s stock, valued at $5,236,922.32. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the sale, the insider now directly owns 27,364 shares in the company, valued at approximately $5,236,922.32. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Thomas J. Wilson sold 90,000 shares of the company’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total value of $16,140,600.00. Following the completion of the sale, the chief executive officer now owns 88,552 shares of the company’s stock, valued at $15,880,915.68. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 192,530 shares of company stock valued at $34,967,665. Corporate insiders own 1.80% of the company’s stock.
Allstate Trading Down 0.4 %
Allstate stock opened at $192.00 on Friday. The company has a market capitalization of $50.67 billion, a price-to-earnings ratio of 42.38, a price-to-earnings-growth ratio of 1.74 and a beta of 0.48. The business’s fifty day simple moving average is $187.73 and its two-hundred day simple moving average is $174.23. The Allstate Co. has a 12 month low of $122.53 and a 12 month high of $198.79. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.49.
Allstate (NYSE:ALL – Get Free Report) last issued its earnings results on Wednesday, July 31st. The insurance provider reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.33 by $1.28. Allstate had a net margin of 5.03% and a return on equity of 24.05%. The business had revenue of $15.71 billion during the quarter, compared to analysts’ expectations of $14.04 billion. During the same period in the previous year, the company earned ($4.42) earnings per share. The business’s revenue for the quarter was up 12.4% compared to the same quarter last year. As a group, equities analysts predict that The Allstate Co. will post 15.19 earnings per share for the current fiscal year.
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Articles
- Five stocks we like better than Allstate
- How to invest in marijuana stocks in 7 stepsĀ
- Talen Energy: A Nuclear Power Stock That Can Keep Winning
- What Are Dividend Achievers? An Introduction
- Rocket Lab Stock Soars Higher: Can It Keep Climbing?
- There Are Different Types of Stock To Invest In
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.